Nelipepimut S

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameNelipepimut S
Drug Alias NameNelipepimut-SCancer vaccine Her2/neu E75- AptheraCancer vaccine E75 - AptheraE75/GM-CSF vaccineCancer vaccine E75 +[8] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulantsCD8-positive T-Lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBulgariaCanada +[13] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer CenterUniformed Services University Of The Health SciencesHenry M. Jackson Foundation For The Advancement Of Military Medicine
China Registration ClassN/A

Develop Information

Active CompaniesCancer Insight Llc
Inactive CompaniesGalena Biopharma Inc
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A